About the Healthcare Industries Cluster
The Berlin-Brandenburg region is one of the leading life sciences and healthcare industries centers in the world. The region’s main strengths are its unique concentration of science, clinics and business and the close network they maintain. Numerous technology parks and networks in different fields, above all biotechnology and medical technology, create an ideal infrastructure for transforming the latest scientific findings into innovative products for the healthcare sector. The systematic innovation policy under the joint innovation strategy of the states Berlin and Brandenburg (innoBB) aims to expand the cluster's development and drive top performance for the regional and global healthcare markets.
The cluster managers welcome you to the HealthCapital cluster website!
Biotechnology and Pharmaceuticals
With cutting-edge research and development from molecules to products, biotechnology in the capital region provides an excellent environment for global players in the pharmaceuticals industry and top scientists.
World leaders in medical technology – many of the over 300 medical technology companies in Berlin-Brandenburg can claim this title. They benefit from the close network between science, business and clinics here.
Innovative Patient Care & Rehabilitation
For medical care and rehabilitation or nursing care – in the capital region, patients of all ages will benefit from capable, highly networked medical care at the highest level.
Health Tourism & Prevention
Berlin-Brandenburg is one of the most attractive healthcare regions with an international flair. It provides lots of space and a wide range of services for prevention, medical tourism and wellness.
Myelo Therapeutics is selected as one of four companies worldwide to participate in Elsevier's incubator project
Myelo Therapeutics GmbH announced today that it was selected as one of four companies worldwide for The Hive, Elsevier's new incubator project for biotech and pharmaceutical start-up firms.
Anti-NMDA receptor encephalitis is an inflammatory disease that affects the central nervous system. It is a rare autoimmune disease that results in the body producing antibodies against the NMDA receptor, a protein that plays an...
Eternygen GmbH, a privately owned Berlin-based metabolic diseases company, today announced the completion of its € 8.0 (approx. US$ 8.3) million Series A funding round. Epidarex Capital led the round, and Evotec AG participated...
Berlin: the place to be for BIO-Europe 2017!
Held once a year, the WHS has grown into the world’s most prominent forum for addressing global health issues. It brings together key leaders from academia, politics, civil society, and the private sector to address the most...